Skip to main content
A complete assessment of TP53 aberrations recommended before initiating ibrutinib in CLL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
A complete assessment of TP53 aberrations recommended before initiating ibrutinib in CLL
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Genomic Medicine
0
1
Leukemia
0
0.95
Cancer
0
0.55
Blood
0
0.32
Specialty
Lead
score
Hematology-Oncology
1
1
Edit Tags